Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Alexion Pharmaceuticals Discloses FCPA Probe

Jaclyn Jaeger | November 6, 2015

Alexion Pharmaceuticals said this week in a securities filing that it is being investigated by the Department of Justice concerning potential violations of the Foreign Corrupt Practices Act.

In a Nov. 2 Form 10-Q filing with the Securities and Exchange Commission, Alexion said it received a request from the Justice Department in October “for the voluntary production of documents and other information pertaining to Alexion’s compliance with the FCPA.”

As previously disclosed, Alexion said it received a subpoena in May in connection with an investigation by the SEC’s Enforcement Division “requesting information related to our grant-making activities and compliance with the FCPA in various countries. The SEC also seeks information related to Alexion’s recalls of specific lots of...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.